Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Sigma Healthcare Ltd (S5YA) vs. Competitors

14 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:S5YASigma Healthcare LtdEUR 1.74EUR 20.38B46.912.35%Moderate BuyUnlock the DE:S5YA analyst price target with TipRanks PremiumDE:S5YAUnlock the DE:S5YA top-analyst price target with TipRanks Premium
AU:MYXMayne Pharma GroupAUD 3.30AUD 270.24M10.64-31.96%Moderate BuyUnlock the AU:MYX analyst price target with TipRanks PremiumDE:S5YA vs AU:MYXUnlock the AU:MYX top-analyst price target with TipRanks Premium
AU:CSLCSLAUD 202.92AUD 97.38B-25.9811.54%Moderate BuyUnlock the AU:CSL analyst price target with TipRanks PremiumDE:S5YA vs AU:CSLUnlock the AU:CSL top-analyst price target with TipRanks Premium
AU:NANNanosonics LimitedAUD 2.83AUD 846.64M48.05-30.30%Strong BuyUnlock the AU:NAN analyst price target with TipRanks PremiumDE:S5YA vs AU:NANUnlock the AU:NAN top-analyst price target with TipRanks Premium
AU:PGCParagon Care LimitedAUD 0.15AUD 248.30M-15.63-52.38%Moderate BuyUnlock the AU:PGC analyst price target with TipRanks PremiumDE:S5YA vs AU:PGCUnlock the AU:PGC top-analyst price target with TipRanks Premium
AU:PKPAlthea Group Holdings Ltd.AUD 0.01AUD 18.75M-5.07-30.00%―Unlock the AU:PKP analyst price target with TipRanks PremiumDE:S5YA vs AU:PKPUnlock the AU:PKP top-analyst price target with TipRanks Premium

Performance Comparison

-80%-60%-40%-20%0%20%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:S5YASigma Healthcare Ltd1.740.138.07%
AU:MYXMayne Pharma Group3.30-1.55-31.96%
AU:CSLCSL202.9227.0615.39%
AU:NANNanosonics Limited2.83-1.11-28.17%
AU:PGCParagon Care Limited0.15-0.17-52.38%
AU:PKPAlthea Group Holdings Ltd.0.01-0.01-30.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts